Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vera Therapeutics Inc Cl A (VERA)

Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vera Therapeutics Inc Cl A 2000 SIERRA POINT PARKWAY SUITE 1200 BRISBANE CA 94005 USA

www.veratx.com Employees: 51 P: 650-770-0077

Description:

Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 2,686,572
Enterprise Value, $K 2,690,772
Shares Outstanding, K 54,828
Annual Sales, $ 0 K
Annual Net Income, $ -95,990 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -46,630 K
EBIT, $ -145,280 K
EBITDA, $ -149,370 K
60-Month Beta 1.03
% of Insider Shareholders 21.70%
% of Institutional Shareholders 99.21%
Float, K 42,930
% Float 78.30%
Short Volume Ratio 0.59

Growth:

1-Year Return 259.77%
3-Year Return 57.05%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.85 on 11/07/24
Next Earnings Date 11/14/24 [--]
Earnings Per Share ttm -2.61
EPS Growth vs. Prev Qtr -37.10%
EPS Growth vs. Prev Year -88.89%
Annual Dividend Yield 0.00%
Dividend Payable Date 01/29/96
Dividend Payout Ratio 0.00%

VERA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.13%
Return-on-Assets % -39.50%
Profit Margin % 0.00%
Debt/Equity 0.17
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 9.21
Book Value/Share 5.27
Interest Coverage -24.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar